Phase I clinical trial 1 article

Phase I clinical trial occupies a distinct place in clinical development and regulated biomedical research as an early human clinical study stage focused primarily on safety, tolerability and dose behavior. Understanding the entity requires connecting first-in-human study to initial human safety assessment, with dose escalation design adding a key design, measurement or mechanistic dimension. Phase I describes an early development stage rather than a permanent property of a drug; the tag is the trial-stage concept, not a statement about any current product status.